Last reviewed · How we verify

Prednisone 1 week

Xinqiao Hospital of Chongqing · FDA-approved active Small molecule

Prednisone 1 week is a Corticosteroid (glucocorticoid) Small molecule drug developed by Xinqiao Hospital of Chongqing. It is currently FDA-approved for Acute inflammatory conditions (non-specific short course), Autoimmune disorders, Allergic reactions. Also known as: Glucocorticoid.

Prednisone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Prednisone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production. Used for Acute inflammatory conditions (non-specific short course), Autoimmune disorders, Allergic reactions.

At a glance

Generic namePrednisone 1 week
Also known asGlucocorticoid
SponsorXinqiao Hospital of Chongqing
Drug classCorticosteroid (glucocorticoid)
TargetGlucocorticoid receptor (GR)
ModalitySmall molecule
Therapeutic areaImmunology / Rheumatology / General anti-inflammatory
PhaseFDA-approved

Mechanism of action

Prednisone acts as a glucocorticoid receptor agonist, translocating to the nucleus to modulate gene expression of inflammatory mediators. It decreases production of cytokines (IL-1, IL-6, TNF-α), reduces immune cell activation and proliferation, and stabilizes lysosomal membranes to limit inflammatory cell degranulation. The 1-week course indicates short-term anti-inflammatory or immunosuppressive therapy for acute conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Prednisone 1 week

What is Prednisone 1 week?

Prednisone 1 week is a Corticosteroid (glucocorticoid) drug developed by Xinqiao Hospital of Chongqing, indicated for Acute inflammatory conditions (non-specific short course), Autoimmune disorders, Allergic reactions.

How does Prednisone 1 week work?

Prednisone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

What is Prednisone 1 week used for?

Prednisone 1 week is indicated for Acute inflammatory conditions (non-specific short course), Autoimmune disorders, Allergic reactions, Asthma exacerbations, Rheumatoid arthritis flares.

Who makes Prednisone 1 week?

Prednisone 1 week is developed and marketed by Xinqiao Hospital of Chongqing (see full Xinqiao Hospital of Chongqing pipeline at /company/xinqiao-hospital-of-chongqing).

Is Prednisone 1 week also known as anything else?

Prednisone 1 week is also known as Glucocorticoid.

What drug class is Prednisone 1 week in?

Prednisone 1 week belongs to the Corticosteroid (glucocorticoid) class. See all Corticosteroid (glucocorticoid) drugs at /class/corticosteroid-glucocorticoid.

What development phase is Prednisone 1 week in?

Prednisone 1 week is FDA-approved (marketed).

What are the side effects of Prednisone 1 week?

Common side effects of Prednisone 1 week include Insomnia, Increased appetite, Mood changes (irritability, anxiety), Hyperglycemia, Gastrointestinal upset, Headache.

What does Prednisone 1 week target?

Prednisone 1 week targets Glucocorticoid receptor (GR) and is a Corticosteroid (glucocorticoid).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing